NM_021098.3:c.926G>A

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_021098.3(CACNA1H):​c.926G>A​(p.Arg309His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000425 in 1,601,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R309C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000026 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

3
9
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 1.68

Publications

4 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10715234).
BP6
Variant 16-1200378-G-A is Benign according to our data. Variant chr16-1200378-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 460194.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000204 (31/152324) while in subpopulation AFR AF = 0.000722 (30/41574). AF 95% confidence interval is 0.000518. There are 0 homozygotes in GnomAd4. There are 17 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 31 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.926G>A p.Arg309His missense_variant Exon 7 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.926G>A p.Arg309His missense_variant Exon 7 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.926G>A p.Arg309His missense_variant Exon 7 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.926G>A p.Arg309His missense_variant Exon 7 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.926G>A p.Arg309His missense_variant Exon 7 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.926G>A p.Arg309His missense_variant Exon 7 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.926G>A p.Arg309His missense_variant Exon 7 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.887G>A p.Arg296His missense_variant Exon 7 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.926G>A p.Arg309His missense_variant Exon 7 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.887G>A p.Arg296His missense_variant Exon 7 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.926G>A p.Arg309His missense_variant Exon 7 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.926G>A p.Arg309His missense_variant Exon 7 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.926G>A p.Arg309His missense_variant Exon 7 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.926G>A p.Arg309His missense_variant Exon 7 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.926G>A p.Arg309His missense_variant Exon 7 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*373G>A non_coding_transcript_exon_variant Exon 6 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.926G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*373G>A 3_prime_UTR_variant Exon 6 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152206
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000483
AC:
11
AN:
227840
AF XY:
0.0000480
show subpopulations
Gnomad AFR exome
AF:
0.000603
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000599
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000352
GnomAD4 exome
AF:
0.0000255
AC:
37
AN:
1449406
Hom.:
0
Cov.:
32
AF XY:
0.0000194
AC XY:
14
AN XY:
720218
show subpopulations
African (AFR)
AF:
0.000844
AC:
28
AN:
33194
American (AMR)
AF:
0.0000231
AC:
1
AN:
43374
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25884
East Asian (EAS)
AF:
0.0000255
AC:
1
AN:
39142
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85322
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49842
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5756
European-Non Finnish (NFE)
AF:
0.00000271
AC:
3
AN:
1106932
Other (OTH)
AF:
0.0000500
AC:
3
AN:
59960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152324
Hom.:
0
Cov.:
32
AF XY:
0.000228
AC XY:
17
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41574
American (AMR)
AF:
0.0000654
AC:
1
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00187
Hom.:
3
Bravo
AF:
0.000215
ESP6500AA
AF:
0.000990
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000834
AC:
10
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 02, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CACNA1H c.926G>A (p.Arg309His) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 4.8e-05 in 227840 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in CACNA1H causing Idiopathic Generalized Epilepsy, allowing no conclusion about variant significance. c.926G>A has been observed in individual(s) affected with Idiopathic Generalized Epilepsy. These report(s) do not provide unequivocal conclusions about association of the variant with Idiopathic Generalized Epilepsy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 36539902). ClinVar contains an entry for this variant (Variation ID: 460194). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Inborn genetic diseases Uncertain:1
Jun 26, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.926G>A (p.R309H) alteration is located in exon 7 (coding exon 6) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 926, causing the arginine (R) at amino acid position 309 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Jun 26, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jun 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.098
T
BayesDel_noAF
Uncertain
0.020
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.55
D;.;.;.
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Benign
0.52
D
LIST_S2
Uncertain
0.88
D;D;D;.
M_CAP
Pathogenic
0.32
D
MetaRNN
Benign
0.11
T;T;T;T
MetaSVM
Uncertain
0.21
D
MutationAssessor
Pathogenic
3.1
M;.;M;M
PhyloP100
1.7
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-1.8
N;.;N;N
REVEL
Uncertain
0.39
Sift
Benign
0.039
D;.;D;D
Sift4G
Uncertain
0.053
T;.;T;T
Polyphen
0.99
D;.;D;D
Vest4
0.39
MVP
0.92
ClinPred
0.28
T
GERP RS
4.4
Varity_R
0.061
gMVP
0.79
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201651793; hg19: chr16-1250378; COSMIC: COSV61993902; COSMIC: COSV61993902; API